In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the Nation

In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the Nation

Item

http://www.wikidata.org/entity/Q35327367

Q35327367

about

Women and Chest Pain: Recognizing the Different Faces of Angina in the Emergency Department Coronary microvascular dysfunction, microvascular angina, and treatment strategies.Pharmacotherapy for coronary microvascular dysfunction Sex differences in cardiovascular disease - Impact on care and outcomes.Coronary Microvascular Dysfunction, Microvascular Angina, and Management.TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation.Sex-specific factors in microvascular angina.Cardiac Syndrome X: update 2014.Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.Evolving strategies for the treatment of microvascular angina in women.Current Diagnostic and Therapeutic Strategies in Microvascular Angina.Microvascular coronary dysfunction and ischemic heart disease: where are we in 2014?Losartan activates sirtuin 1 in rat reduced-size orthotopic liver transplantation.Coronary flow reserve during dobutamine stress in Takotsubo stress cardiomyopathy.Therapy for stable angina in women Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.Cold Pressor Stress Cardiac Magnetic Resonance Myocardial Flow Reserve Is Not Useful for Detection of Coronary Endothelial Dysfunction in Women with Signs and Symptoms of Ischemia and No Obstructive CAD.Association of aortic stiffness and wave reflections with coronary flow reserve in women without obstructive coronary artery disease: An ancillary study from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluatio Increased wave reflection and ejection duration in women with chest pain and nonobstructive coronary artery disease: ancillary study from the Women's Ischemia Syndrome Evaluation.Non-invasive quantification of coronary vascular dysfunction for diagnosis and management of coronary artery disease.Gender disparity in cardiovascular disease: bias or biology?Management of microvascular angina pectoris.Coronary microvascular dysfunction: mechanisms and functional assessment.Microvascular angina: an update on diagnosis and treatment.Vasotonic Angina as a Cause of Myocardial Ischemia in Women.Coronary endothelial dysfunction in non-obstructive coronary artery disease: Risk, pathogenesis, diagnosis and therapy.Treatment of Angina Pectoris Associated with Coronary Microvascular Dysfunction.Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.Coronary microvascular dysfunction in diabetes mellitus.Obesity, inflammation and brachial artery flow-mediated dilatation: therapeutic targets in patients with microvascular angina (cardiac syndrome X).Stable ischemic heart disease in women: current perspectives.Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women.Presentation, management, and outcomes of ischaemic heart disease in women.A practical clinical approach to utilize cardiopulmonary exercise testing in the evaluation and management of coronary artery disease: a primer for cardiologists.Coronary microvascular dysfunction assessed by intracoronary acetylcholine provocation testing is a frequent cause of ischemia and angina in patients with exercise-induced electrocardiographic changes and unobstructed coronary arteries.High-Sensitivity C-Reactive Protein Is a Predictor of Coronary Microvascular Dysfunction in Patients with Ischemic Heart Disease.Late gadolinium enhancement on cardiac magnetic resonance imaging is associated with coronary endothelial dysfunction in patients with dilated cardiomyopathy.Effect of ACE-inhibition on coronary microvascular function and symptoms in normotensive women with microvascular angina: A randomized placebo-controlled trial.

P2860

Q26746172-6DFA14B0-7203-4175-80F5-E940591BA753 Q26861073-9302252A-194F-49E0-8689-7EDBBEBA82BE Q26991627-B8307BB9-FE58-4DDF-8153-F9C0E73A7EF5 Q30234726-25779D9E-3A47-4ECD-94B5-2102DC3CF8E8 Q30277875-35D919F6-00B9-4DAB-B8BD-95FA7EDD596D Q33572992-13F963CD-C8F3-4519-A09C-578EB10D7D07 Q33725441-14DC5D93-372A-4B0B-B93C-09914D79E7A5 Q33818831-3E699D98-3827-44A3-8C25-F9292E80E279 Q34007353-A4F86595-9ACD-41C0-976C-E5347771783A Q34313090-DBAECE6E-73C5-443D-97A4-358AC0538A2C Q34317991-C7C5EF50-22AB-4C58-A78F-EA9437BA5A35 Q35077560-D22D7C2C-D85E-41F6-BE0F-5D0D03A28B56 Q35108848-4CE2E192-29C9-4845-AD72-5DB239FADB70 Q35843026-E8716E44-CCC7-4BC0-A796-37DF85C57A6F Q35885051-DDA39A76-10F9-48D3-B830-758CA561E3AB Q36137967-55018BD4-A8B3-4D9F-8A11-6AE7A4421F03 Q36202061-3C2F43D9-12F1-423C-BE13-1D2DC68622D5 Q36247712-47AA685E-91A9-4AE3-8EC6-73801C11ABB2 Q36389912-0E3A4DF0-36D9-4C1F-A683-7AA63C9AC3DD Q37154275-A3110044-8F90-4CC1-AD44-97B281EB0CFB Q38020118-D09888B4-E1C8-482A-8F1E-07C107E308E2 Q38067775-ED6ED799-2148-43E3-A605-74322664B879 Q38156702-35FD8AE2-CDF3-4F93-BCA8-55EDA7DC0258 Q38259726-2F006DC0-98D7-4F85-82B6-FC8C8D733DD6 Q38373871-4111CCC2-50BF-4C20-AF60-06E6C97013D3 Q38504653-B49CD74D-4ACE-4A54-9BD7-12F302F5F40E Q38671287-634E8819-8EF6-4107-98C1-26AFA2FF38AC Q38846938-7A83BBD7-B152-4EC6-843C-5C74E0BFBF6B Q39176512-E351E289-5C71-4509-BF22-69DBB2822081 Q39393549-2F890B3D-617F-4D6D-881E-06F5668CDDF6 Q39644576-BF051274-AC8A-41FA-8033-75CC0B767918 Q42370573-709D7F0D-CEB1-46AD-88E9-1E72B07A1C6F Q43118454-26F173E5-7C1A-4422-9882-3349B4CA3E9C Q44960920-A3C05D14-498B-4ABB-B047-1A46F2CC38CA Q47310709-3829FD36-DF8C-49CE-BB23-D8C1C52491E7 Q48316095-078BB975-D76A-4952-B5E3-4712560907B2 Q49254663-AE6B3031-010F-4139-9714-E1413DA0896A Q50100084-550249FA-E38A-4B70-AB20-1B9815C2367A Q55286779-DDB2B8E0-B6F9-4122-AF18-A942FA882C3C

P2860

In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the Nation

Item

http://www.wikidata.org/entity/Q35327367

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu